Prosight Management, LP — 13F Holdings

2026 Q3  ·  45 Positions

2026 Q3 Portfolio Activity

In 2026 Q3, Prosight Management, LP maintained a portfolio of 45 distinct positions. The most significant new addition was PRIVIA HEALTH GROUP INC, now representing 4.01% of the total fund value. They heavily accumulated shares in ABIVAX SA, increasing the position by 250.9%. The fund also reduced its exposure to BOSTON SCIENTIFIC CORP by 56.7%.
Position History hover any row below to update
Loading…
Prosight Management, LP Dallas, TX Hedge Fund / Alternative Investment Manager AUM $515M
PCA Score Concentration Risk
Risk ENB
Total Positions
45
Quarter
2026 Q3
Top Holding
GLPG (11.5%)
Top 10 Concentration
70.6%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-45 of 45

Prosight Management, LP Full Holdings List — 2026 Q3

Stock History Sector / Type Port % Prev % Rank / Prev Conviction
Freshness
Change % Change Influence Shares Mkt Value Avg Cost Price Held 1st Owned Source Source Date Date Reported
GLPG
LAKEFRONT BIOTH...
Healthcare 11.49% 10.56% #1
Prev: #1
6.5
—
-44,944 -2.2%
P
S
1,998,400 $59,252,560 2018 Q4 13F Filing 2026-09-30 2026-11-13
STTK
SHATTUCK LABS I...
Healthcare 10.12% 7.12% #2 3
Prev: #5
8.0
—
1,690,217 28.4%
P
S
7,648,094 $52,160,001 2021 Q3 13F Filing 2026-09-30 2026-11-13
JANX
JANUX THERAPEUT...
Healthcare 9.87% 10.07% #3 1
Prev: #2
4.9
—
-861,281 -22.6%
P
S
2,943,200 $50,858,496 2024 Q3 13F Filing 2026-09-30 2026-11-13
NKTR
NEKTAR THERAPEU...
Healthcare 9.22% 9.74% #4 1
Prev: #3
4.7
—
-25,000 -3.1%
P
S
785,000 $47,527,825 2025 Q4 13F Filing 2026-09-30 2026-11-13
ABVX
ABIVAX SA
Healthcare 7.24% 2.47% #5 9
Prev: #14
6.4
—
269,400 250.9%
P
S
376,794 $37,310,142 2025 Q4 13F Filing 2026-09-30 2026-11-13
INSM
INSMED INC
Healthcare 5.27% 6.90% #6
Prev: #6
2.1
—
-137,521 -36.6%
P
S
238,088 $27,175,364 2023 Q1 13F Filing 2026-09-30 2026-11-13
BSX
BOSTON SCIENTIF...
Healthcare 4.66% 9.34% #7 3
Prev: #4
1.9
—
-720,273 -56.7%
P
S
550,000 $24,007,500 2025 Q3 13F Filing 2026-09-30 2026-11-13
IRTC
IRHYTHM HOLDING...
Healthcare 4.43% 3.39% #8 3
Prev: #11
4.3
—
35,480 21.4%
P
S
200,980 $22,843,387 2021 Q2 13F Filing 2026-09-30 2026-11-13
ALKS
ALKERMES PLC
Healthcare 4.32% 3.56% #9 1
Prev: #10
4.2
—
155,611 39.5%
P
S
550,000 $22,286,000 2022 Q3 13F Filing 2026-09-30 2026-11-13
PRVA
PRIVIA HEALTH G...
Healthcare 4.01% — #10
Prev: #—
5.1
—
1,049,752 —
NEW
1,049,752 $20,669,617 2023 Q4 13F Filing 2026-09-30 2026-11-13
MLYS
MINERALYS THERA...
Healthcare 3.90% 2.09% #11 5
Prev: #16
4.6
—
350,205 77.9%
P
S
800,000 $20,104,000 2026 Q2 13F Filing 2026-09-30 2026-11-13
ZYME
ZYMEWORKS INC
Healthcare 3.71% 3.04% #12 1
Prev: #13
3.5
—
46,666 6.9%
P
S
721,100 $19,101,939 2023 Q3 13F Filing 2026-09-30 2026-11-13
SNDX
SYNDAX PHARMACE...
Healthcare 2.96% 4.52% #13 5
Prev: #8
1.2
—
-387,418 -32.3%
P
S
812,582 $15,276,542 2024 Q2 13F Filing 2026-09-30 2026-11-13
KURA
KURA ONCOLOGY I...
Healthcare 2.65% 3.82% #14 5
Prev: #9
1.1
—
-746,964 -36.9%
P
S
1,275,000 $13,655,250 2018 Q2 13F Filing 2026-09-30 2026-11-13
DNLI
DENALI THERAPEU...
Healthcare 2.21% — #15
Prev: #—
4.4
—
550,700 —
NEW
550,700 $11,382,969 2026 Q3 13F Filing 2026-09-30 2026-11-13
PRAX
PRAXIS PRECISIO...
Healthcare 2.06% — #16
Prev: #—
4.3
—
36,400 —
NEW
36,400 $10,600,772 2026 Q3 13F Filing 2026-09-30 2026-11-13
HQY
HEALTHEQUITY IN...
Healthcare 1.99% — #17
Prev: #—
4.3
—
115,796 —
NEW
115,796 $10,243,314 2026 Q3 13F Filing 2026-09-30 2026-11-13
BBIO
BRIDGEBIO PHARM...
Healthcare 1.91% — #18
Prev: #—
4.3
—
150,000 —
NEW
150,000 $9,870,000 2022 Q4 13F Filing 2026-09-30 2026-11-13
ALNY
ALNYLAM PHARMAC...
Healthcare 1.77% 5.09% #19 12
Prev: #7
0.7
—
-61,080 -62.3%
P
S
37,000 $9,129,380 2021 Q4 13F Filing 2026-09-30 2026-11-13
HUM
HUMANA INC
Healthcare 1.63% — #20
Prev: #—
4.2
—
22,000 —
NEW
22,000 $8,394,540 2019 Q3 13F Filing 2026-09-30 2026-11-13
ENOV
ENOVIS CORPORAT...
Healthcare 0.95% — #21
Prev: #—
3.9
—
267,432 —
NEW
267,432 $4,885,983 2026 Q3 13F Filing 2026-09-30 2026-11-13
OKUR
ONKURE THERAPEU...
Healthcare 0.70% 0.77% #22 2
Prev: #24
2.8
—
346,578 35.4%
P
S
1,325,570 $3,612,178 2024 Q4 13F Filing 2026-09-30 2026-11-13
QTRX
QUANTERIX CORP
Healthcare 0.59% — #23
Prev: #—
3.7
—
825,000 —
NEW
825,000 $3,060,750 2026 Q3 13F Filing 2026-09-30 2026-11-13
GENB
GENERATE BIOMED...
Healthcare 0.42% — #24
Prev: #—
3.7
—
144,756 —
NEW
144,756 $2,174,235 2026 Q3 13F Filing 2026-09-30 2026-11-13
ANTX
AN2 THERAPEUTIC...
Healthcare 0.36% 0.40% #25 4
Prev: #29
0.1
—
-123,761 -26.1%
P
S
350,877 $1,866,666 2026 Q1 13F Filing 2026-09-30 2026-11-13
PLRX
PLIANT THERAPEU...
Healthcare 0.34% 0.27% #26 4
Prev: #30
2.1
—
234,233 17.1%
P
S
1,604,466 $1,732,823 2025 Q1 13F Filing 2026-09-30 2026-11-13
RCKT
ROCKET PHARMACE...
Healthcare 0.30% 0.41% #27 1
Prev: #28
0.6
—
-104,976 -15.0%
P
S
595,024 $1,564,913 2021 Q4 13F Filing 2026-09-30 2026-11-13
RNTX
REIN THERAPEUTI...
Healthcare 0.26% 0.20% #28 6
Prev: #34
3.1
—
560,197 50.9%
P
S
1,660,197 $1,334,798 2024 Q2 13F Filing 2026-09-30 2026-11-13
COYA
COYA THERAPEUTI...
Healthcare 0.22% 0.17% #29 6
Prev: #35
2.6
—
59,600 35.1%
P
S
229,600 $1,150,296 2026 Q1 13F Filing 2026-09-30 2026-11-13
CRBP
CORBUS PHARMACE...
Healthcare 0.22% 1.05% #30 10
Prev: #20
0.1
—
-481,617 -74.1%
P
S
168,383 $1,148,372 2024 Q1 13F Filing 2026-09-30 2026-11-13
IMRX
IMMUNEERING COR...
Healthcare 0.12% 0.03% #31 5
Prev: #36
3.0
—
113,139 306.9%
P
S
150,000 $614,250 2024 Q2 13F Filing 2026-09-30 2026-11-13
ADCT
ADC THERAPEUTIC...
Healthcare 0.09% 1.44% #32 15
Prev: #17
0.0
—
-7,424,849 -94.9%
P
S
399,900 $487,878 2022 Q3 13F Filing 2026-09-30 2026-11-13
ASGN
EVERFORTH INC
Technology 0.00% 0.21%
Sold All 😨
(Was: #33)
0.0
—
-67,500 -100.0%
CLOSED
— $— 2018 Q4 13F Filing 2026-09-30 2026-11-13
MGTX
MEIRAGTX HLDGS ...
Healthcare 0.00% 0.21%
Sold All 😨
(Was: #32)
0.0
—
-90,000 -100.0%
CLOSED
— $— 2018 Q3 13F Filing 2026-09-30 2026-11-13
TECX
TECTONIC THERAP...
Healthcare 0.00% 0.24%
Sold All 😨
(Was: #31)
0.0
—
-39,731 -100.0%
CLOSED
— $— 2024 Q2 13F Filing 2026-09-30 2026-11-13
KIDS
ORTHOPEDIATRICS...
Healthcare 0.00% 0.52%
Sold All 😨
(Was: #27)
0.0
—
-157,500 -100.0%
CLOSED
— $— 2020 Q3 13F Filing 2026-09-30 2026-11-13
PFE
PFIZER INC
Healthcare 0.00% 0.56%
Sold All 😨
(Was: #26)
0.0
—
-135,366 -100.0%
CLOSED
— $— 2024 Q1 13F Filing 2026-09-30 2026-11-13
EBS
EMERGENT BIOSOL...
Healthcare 0.00% 0.66%
Sold All 😨
(Was: #25)
0.0
—
-459,952 -100.0%
CLOSED
— $— 2026 Q1 13F Filing 2026-09-30 2026-11-13
OPCH
OPTION CARE HEA...
Healthcare 0.00% 0.98%
Sold All 😨
(Was: #23)
0.0
—
-270,716 -100.0%
CLOSED
— $— 2021 Q2 13F Filing 2026-09-30 2026-11-13
WGS
GENEDX HOLDINGS...
Healthcare 0.00% 1.01%
Sold All 😨
(Was: #22)
0.0
—
-85,500 -100.0%
CLOSED
— $— 2025 Q4 13F Filing 2026-09-30 2026-11-13
PRCT
PROCEPT BIOROBO...
Healthcare 0.00% 1.04%
Sold All 😨
(Was: #21)
0.0
—
-268,269 -100.0%
CLOSED
— $— 2021 Q4 13F Filing 2026-09-30 2026-11-13
ISRG
INTUITIVE SURGI...
Healthcare 0.00% 1.16%
Sold All 😨
(Was: #19)
0.0
—
-17,000 -100.0%
CLOSED
— $— 2025 Q1 13F Filing 2026-09-30 2026-11-13
ICUI
ICU MED INC
Healthcare 0.00% 1.29%
Sold All 😨
(Was: #18)
0.0
—
-51,000 -100.0%
CLOSED
— $— 2026 Q1 13F Filing 2026-09-30 2026-11-13
CRNX
CRINETICS PHARM...
Healthcare 0.00% 2.42%
Sold All 😨
(Was: #15)
0.0
—
-374,666 -100.0%
CLOSED
— $— 2025 Q2 13F Filing 2026-09-30 2026-11-13
VEEV
VEEVA SYS INC
Healthcare 0.00% 3.25%
Sold All 😨
(Was: #12)
0.0
—
-106,200 -100.0%
CLOSED
— $— 2025 Q4 13F Filing 2026-09-30 2026-11-13
Showing 1-45 of 45 holdings

Unlock Full Prosight Management, LP Analysis

PRO subscribers get access to all historical quarters, Excel/CSV exports, Portfolio Concentration Analytics (PCA), and Risk-Based ENB.

Full Historical Quarters
Excel & CSV Export
PCA & Risk-Based ENB
Auto Cost Basis
Position Change Alerts
Price-Held Analytics
Full history →